Literature DB >> 21286077

Hodgkin's Disease: Treatment and Prognosis.

V W Ing.   

Abstract

The prognosis of Hodgkin's disease (HD) has improved impressively in the past decade. Presently, no stage of disease is beyond cure or expectancy of a long disease-free survival. The extent of disease involvement governs the choice of therapy. The treatment of choice for localized disease is irradiation, although the techniques used vary considerably among different centres. Combination chemotherapy is recommended for stages 3B and 4. The management of stage 3A and some high-risk subsets of HD remains controversial. In specific situations, combined treatments are indicated. Therapy associated complications, immediate or delayed, deserve greater attention. Ironically, their impact upon the improved survivors might be morbid and devastating.

Entities:  

Year:  1982        PMID: 21286077      PMCID: PMC2306384     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  19 in total

1.  Long term remissions with combined modality therapy for advanced Hodgkin's disease.

Authors:  L R Prosnitz; L R Farber; J J Fischer; J R Bertino; D B Fischer
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

2.  Limited extranodal Hodgkin's disease. Unfavorable prognosis and therapeutic implications.

Authors:  J A Levi; P H Wiernik
Journal:  Am J Med       Date:  1977-09       Impact factor: 4.965

3.  Hematologic neoplasia in patients treated for Hodgkin's disease.

Authors:  C N Coleman; C J Williams; A Flint; E J Glatstein; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

4.  Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.

Authors:  S A Weller; E Glatstein; H S Kaplan; S A Rosenberg
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

5.  Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin's disease?

Authors:  R L Goodman; A J Piro; S Hellman
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

6.  Relationship of histological findings to survival in Hodgkin's disease.

Authors:  J J Butler
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  The place of radiation therapy in the treatment of Hodgkin's disease.

Authors:  S Hellman; P Mauch; R L Goodman; D S Rosenthal; W C Moloney
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

8.  Staging laparotomy in Hodgkin's disease.

Authors:  W R Sandusky; R C Jones; J S Horsley; W L Marsh; T W Tillack; C J Tegtmeyer; C E Hess
Journal:  Ann Surg       Date:  1978-05       Impact factor: 12.969

9.  Role of laparotomy and splenectomy in the management of Hodgkin's disease.

Authors:  L R Prosnitz; S B Nuland; M M Kligerman
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

10.  MVPP chemotherapy regimen for advanced Hodgkin's disease.

Authors:  S B Sutcliffe; P F Wrigley; J Peto; T A Lister; A G Stansfeld; J M Whitehouse; D Crowther; J S Malpas
Journal:  Br Med J       Date:  1978-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.